Cardiac 3D MRI in Pediatric Cancer Patients

Status Withdrawn

Clinical Trial Summary

This is a non-randomized prospective pilot study in a single academic center with historic controls. This study will compare Cardiac Magnetic Resonance Images (MRI) of patients who have undergone childhood cancer treatment that has cardio-toxic effects to historic controls. The ultimate goal of this study is to develop a safe and effective method for early diagnosis of heart problems in children who are receiving chemotherapy treatments that may be toxic to the heart.

Clinical Trial Description

The following tests and procedures will be performed after consent has been obtained. All tests and procedures noted below are being done for the sole purpose of the study:

Visit 1. Subjects will be asked to complete some questionnaires and answer questions regarding smoking status and use of alcohol or smokeless tobacco. We will also gather basic information such as age, height, weight, gender, ethnicity, race, pertinent medical history as well as collect vital sign information (height, weight, blood pressure, heart and respiratory rate.) Next, subjects will undergo a routine transthoracic echocardiogram.

Visit 2. Following the completion of the echocardiogram, and if selected to take part in the study, subjects will be schedule for a cardiac MRI test within a 3 months period.

When subjects come in for Visit 2, they will receive a 12 lead electrocardiograph (ECG) before the cardiac 3D MRI.

All females who are capable of becoming pregnant, except those who are age 11 and under, will then undergo urine pregnancy testing. If it is found that you are pregnant you will not be allowed to be in the study. If the female is under 18 and a positive pregnancy test result is obtained, we will inform both the participant and her parent/guardian.

Subjects may then be placed in a "simulated" MRI to teach them what it will be like to enter the scanner and also train them on how to breathe calmly and regularly during the scan.

Training will involve the use of a PrimeSense 3D sensor, similar to the cameras used in active videogame systems such as the Xbox Kinect, which will generate a 3D picture of their chest as they breathe. Following this training session, subjects will then undergo cardiac 3D MRI. Study participations will end after this visit. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Childhood Cancer

Clinical Trial Details

NCT number	NCT02130934
Study type	Observational
Source	University of Kentucky
Contact
Status	Withdrawn
Phase	N/A
Start date	May 2014
Completion date	March 2016

View Details

See also
Status	Clinical Trial	Phase
Enrolling by invitation	`NCT04202094` - Fertility in Young Adults Who Did (Not) Store Testicular Tissue Before a Treatment Leading to Fertility Problems	N/A
Recruiting	`NCT03336931` - PRecISion Medicine for Children With Cancer
Not yet recruiting	`NCT05048771` - Fertility and Temporality in Pediatric Oncology
Completed	`NCT05982379` - Motivation Program for Children With Cancer	N/A
Completed	`NCT04066218` - Sexual Function Screening in Childhood Cancer Survivors
Completed	`NCT03934060` - Strength Training and ADLs in Childhood Leukemia and Lymphoma Patients	N/A
Active, not recruiting	`NCT03938324` - Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions	N/A
Active, not recruiting	`NCT04032743` - Risk Factors and Treatment Outcome of Oncology Children Hospitalized in the Intensive Care Unit Due to Sepsis
Recruiting	`NCT04328350` - Social Experiences of Adolescents and Young Adults With Cancer
Not yet recruiting	`NCT05457153` - Technology-Based Well-Being Process Program (WEBEPROP) for Children and Adolescents in Palliative Care	N/A
Recruiting	`NCT05641961` - Mobile App to Help Survivors of Childhood Cancer Navigate Long-Term Follow-Up Care	N/A
Completed	`NCT06179914` - Resilience Models in Adolescence and Youth With Cancer in Taiwan
Completed	`NCT03951246` - Cognitive and Motor Training in Pediatric Posterior Fossa Tumor Survivors	N/A
Not yet recruiting	`NCT04902313` - Cultivating Resilience in Oncology Practice	N/A
Completed	`NCT03160768` - Feasibility of Isolating P16 Expression
Completed	`NCT02216604` - Exercise in Pediatric Cancer Patient Undergoing Anti-Cancer Treatment	N/A
Recruiting	`NCT03852758` - Green Exercise for Cancer - Creating Opportunities for Survivors	N/A
Recruiting	`NCT06053268` - Mindfulness Interventions to Improve Health Activation, Coping, and Stress Among Childhood Cancer Survivors	N/A
Not yet recruiting	`NCT05754840` - CANnabinoids in Pediatric ONCology	Phase 1/Phase 2
Not yet recruiting	`NCT06208657` - Optimal Precision TherapIes to CustoMISE Care in Childhood and Adolescent Cancer	Phase 1/Phase 2

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.